NewslettersPancreatic Cell NewsUncategorizedIMB5036 Inhibits Human Pancreatic Cancer Growth Primarily through Activating NecroptosisBy Justin.choi - November 30, 2021015MLKL inhibitor NSA attenuated the killing effect of IMB5036 on pancreatic cancer cells. IMB5036 stimulated translocation of MLKL and p-MLKL from cytoplasm to cell membrane.[Basic & Clinical Pharmacology & Toxicology] 6445212 AAAAAAAA items 1 apa 0 default asc 1 169535 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract